Skip to content

Investigator

Richard E Pratley

ADVENTHEALTH ORLANDO · funded by NIDDK

Companies
3

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$3.5M

Summed across those awards.

First award
Sep 25, 2022

Latest Sep 11, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U01

    Ketone Monitoring Approaches for DKA Risk Mitigation in People with T1D on Adjunctive SGLT2 Inhibitors (KARMA)

    $2.5M

    Sep 11, 2025NIDDKADVENTHEALTH ORLANDONIH RePORTER · 11127155 (opens the source filing in a new tab)

  2. U01

    Advanced Insulin Delivery to Reduce Impaired Awareness of Hypoglycemia in a T1D Cohort (AIDRIAHT1C)

    $328k

    Sep 25, 2022NIDDKADVENTHEALTH ORLANDONIH RePORTER · 11076628 (opens the source filing in a new tab)

  3. U01

    Advanced Insulin Delivery to Reduce Impaired Awareness of Hypoglycemia in a T1D Cohort (AIDRIAHT1C)

    $741k

    Sep 25, 2022NIDDKADVENTHEALTH ORLANDONIH RePORTER · 11319846 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources